Todd W Miller

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Topics

Drug Administration

Estrogen Receptor

Decision Making

Endoplasmic Reticulum

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer metastasis reviews

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy Without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
The role of cancer cell bioenergetics in dormancy and drug resistance. Cancer metastasis reviews 42 (1) (2023)
Steven Tau, Todd W Miller
The role of cancer cell bioenergetics in dormancy and drug resistance. Cancer metastasis reviews 42 (1) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy Without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling Iv, Eugene Demidenko, Todd W Miller
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Steven Tau, Todd W Miller
The role of cancer cell bioenergetics in dormancy and drug resistance. Cancer metastasis reviews 42 (1) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
The role of cancer cell bioenergetics in dormancy and drug resistance. Cancer metastasis reviews (2023)
Nicole A Traphagen, Gary N Schwartz, Steven Tau, Alyssa M Roberts, Amanda Jiang, Sarah R Hosford, Jonathan D Marotti, Abigail E Goen, Bianca A Romo, Anneka L Johnson, Emily-Claire K Duffy, Eugene Demidenko, Paul Heverly, Yaron Mosesson, Shannon M Soucy, Fred Kolling Iv, Todd W Miller
Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling Iv, Eugene Demidenko, Todd W Miller
Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Steven Tau, Todd W Miller
The role of cancer cell bioenergetics in dormancy and drug resistance. Cancer metastasis reviews 42 (1) (2023)
Joseph D Phillips, Darcy B Pooler, Dylan B Ness, Kayla Fay, Steven Tau, Eugene Demidenko, Riley A Hampsch, Lionel D Lewis, Todd W Miller
Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients. British journal of clinical pharmacology (2022)
Nicole A Traphagen, Sarah R Hosford, Amanda Jiang, Jonathan D Marotti, Brooke L Brauer, Eugene Demidenko, Todd W Miller
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer. Oncogene 40 (19) (2021)
Mary D Chamberlin, Jason D Wells, Kevin Shee, Jennifer R Bean, Jonathan D Marotti, Wendy A Wells, Heidi W Trask, Fred W Kolling, Ananta Bhatt, Peter A Kaufman, Gary N Schwartz, John M Gemery, Nancy J McNulty, Michael J Tsapakos, Richard J Barth, Bradley A Arrick, Jiang Gui, Todd W Miller
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. Breast cancer research and treatment 182 (3) (2020)
Sarah R Hosford, Kevin Shee, Jason D Wells, Nicole A Traphagen, Jennifer L Fields, Riley A Hampsch, Arminja N Kettenbach, Eugene Demidenko, Todd W Miller
Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer. Molecular oncology 13 (8) (2019)
Kevin Shee, Wei Yang, John W Hinds, Riley A Hampsch, Frederick S Varn, Nicole A Traphagen, Kishan Patel, Chao Cheng, Nicole P Jenkins, Arminja N Kettenbach, Eugene Demidenko, Philip Owens, Anthony C Faber, Todd R Golub, Ravid Straussman, Todd W Miller
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. The Journal of experimental medicine 215 (3) (2018)
Jonathan D Marotti, Kristen E Muller, Laura J Tafe, Eugene Demidenko, Todd W Miller
P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site. International journal of breast cancer 2017 (2017)